CRE™ RX M00558930Recalls & reported problems
Boston Scientific Corporation · Biliary Balloon Dilatation Catheter · Class 2
All models of CRE RX (9)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 17
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 17 adverse event reports that list this exact device (DI 08714729965480), received between Jun 26, 2019 and Jul 16, 2026 — classified as 17 malfunctions.
The most frequently reported specific device problem is “Burst Container or Vessel” (6 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Burst Container or Vessel6
- Entrapment of Device4
- Detachment of Device or Device Component3
- Material Puncture/Hole3
- Problem with Sterilization3
- Tear, Rip or Hole in Device Packaging2
- Use of Device Problem2
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions14
- No Consequences Or Impact To Patient3
Recent adverse event reports
The 17 most recent of 17 reports, in the reporter's own words as published by the FDA.
MalfunctionJul 16, 2026Tear, Rip or Hole in Device Packaging
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25850516 ↗MalfunctionJul 16, 2026Tear, Rip or Hole in Device Packaging
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25850252 ↗MalfunctionJun 19, 2026Burst Container or Vessel
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CRE RX BILIARY DILATATION BALLOON WAS ATTEMPTED TO BE USED DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE PERFORMED ON (B)(6) 2026. DURING THE PROCEDURE, THE BALLOON RUPTURED. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. THE PATIENT'S CONDITION AT THE CONCLUSION OF THE PROCEDURE WAS REPORTED TO BE STABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25568569 ↗MalfunctionMar 5, 2026Burst Container or Vessel; Inflation Problem
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CRE RX DILATATION BALLOON WAS ATTEMPTED TO BE USED IN THE BILE DUCT DURING A STONE REMOVAL PROCEDURE FOR A BILE DUCT STONE PERFORMED ON (B)(6) 2026. DURING THE PROCEDURE, THE BALLOON COULD NOT BE PROPERLY EXPANDED AND REPORTEDLY RUPTURED. IT WAS REPORTED THAT THE BALLOON BURST AT A PRESSURE/DIAMETER OF 3ATM/10MM. NO PIECE OF BALLOON DETACHED INSIDE THE PATIENT. THE PROCEDURE WAS COMPLETED WITH ANOTHER DEVICE THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24527452 ↗MalfunctionJun 23, 2025Entrapment of Device; Problem with Sterilization; Entrapment of Device; Problem with Sterilization
NOTE: THIS REPORT PERTAINS TO ONE OF FOUR PROCEDURES INVOLVING ONE CRE RX BILIARY DILATATION BALLOON. IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CRE RX BILIARY DILATATION BALLOON WAS USED IN THE COMMON BILE DUCT DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE PERFORMED ON (B)(6) 2025. DURING THE PROCEDURE PERFORMED ON (B)(6) 2025, THE CRE RX TUNNEL (BLACK SHEATH) WAS DETACHED AND STUCK IN THE ENDOSCOPE. SCOPE WAS PUT THROUGH CLEANING PROCESS, AND INCLUDED MANUAL CLEAN, AND AUTO WASHING PROCEDURE. WITHOUT THE TEAM BEING AWARE, THE SCOPE WAS USED ON ANOTHER PROCEDURE ON (B)(6) 2025, STILL NO REALIZATION OF SHEATH INSIDE THE WORKING CHANNEL. THEN THE SCOPE WAS USED IN ANOTHER TWO SEPARATE PROCEDURES ON (B)(6) 2025, IN THE SECOND CASED PERFORMED ON (B)(6) 2025, IT WAS OBSERVED THAT THE BLACK SHEATH COME OUT OF THE BIOPSY PORT ON THE SCOPE WHEN THEY WITHDREW THE FORCEPS BACK INTO THE ENDOSCOPE. IT WAS REPORTED THAT THE RX TUNNEL DID NOT DETACH INSIDE THE PATIENT. THEY HAVE TO TEST THE FIRST PATIENT (SOURCE) TO SEE IF THERE IS ANY FOR BLOOD-BORNE PATHOLOGY (BBP) WHICH COULD HAVE BEEN PASSED ON TO OTHER PATIENTS AT LATER PROCEDURES. THERE WERE NO PAT
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22311489 ↗MalfunctionJun 23, 2025Entrapment of Device; Use of Device Problem; Detachment of Device or Device Component; Entrapment of Device; Use of Device Problem; Detachment of Device or Device Component
NOTE: THIS REPORT PERTAINS TO ONE OF FOUR PROCEDURES INVOLVING ONE CRE RX BILIARY DILATATION BALLOON. IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CRE RX BILIARY DILATATION BALLOON WAS USED IN THE COMMON BILE DUCT DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE PERFORMED ON (B)(6) 2025. DURING THE PROCEDURE PERFORMED ON (B)(6) 2025, THE CRE RX TUNNEL (BLACK SHEATH) WAS DETACHED AND STUCK IN THE ENDOSCOPE. SCOPE WAS PUT THROUGH CLEANING PROCESS, AND INCLUDED MANUAL CLEAN, AND AUTO WASHING PROCEDURE. WITHOUT THE TEAM BEING AWARE, THE SCOPE WAS USED ON ANOTHER PROCEDURE ON (B)(6) 2025, STILL NO REALIZATION OF SHEATH INSIDE THE WORKING CHANNEL. THEN THE SCOPE WAS USED IN ANOTHER TWO SEPARATE PROCEDURES ON (B)(6) 2025, IN THE SECOND CASED PERFORMED ON (B)(6) 2025, IT WAS OBSERVED THAT THE BLACK SHEATH COME OUT OF THE BIOPSY PORT ON THE SCOPE WHEN THEY WITHDREW THE FORCEPS BACK INTO THE ENDOSCOPE. IT WAS REPORTED THAT THE RX TUNNEL DID NOT DETACH INSIDE THE PATIENT. THEY HAVE TO TEST THE FIRST PATIENT (SOURCE) TO SEE IF THERE IS ANY FOR BLOOD-BORNE PATHOLOGY (BBP) WHICH COULD HAVE BEEN PASSED ON TO OTHER PATIENTS AT LATER PROCEDURES. THERE WERE NO PAT
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22311471 ↗MalfunctionJun 23, 2025Entrapment of Device; Problem with Sterilization; Entrapment of Device; Problem with Sterilization
NOTE: THIS REPORT PERTAINS TO ONE OF FOUR PROCEDURES INVOLVING ONE CRE RX BILIARY DILATATION BALLOON. IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CRE RX BILIARY DILATATION BALLOON WAS USED IN THE COMMON BILE DUCT DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE PERFORMED ON (B)(6) 2025. DURING THE PROCEDURE PERFORMED ON (B)(6) 2025, THE CRE RX TUNNEL (BLACK SHEATH) WAS DETACHED AND STUCK IN THE ENDOSCOPE. SCOPE WAS PUT THROUGH CLEANING PROCESS, AND INCLUDED MANUAL CLEAN, AND AUTO WASHING PROCEDURE. WITHOUT THE TEAM BEING AWARE, THE SCOPE WAS USED ON ANOTHER PROCEDURE ON (B)(6) 2025, STILL NO REALIZATION OF SHEATH INSIDE THE WORKING CHANNEL. THEN THE SCOPE WAS USED IN ANOTHER TWO SEPARATE PROCEDURES ON (B)(6) 2025, IN THE SECOND CASED PERFORMED ON (B)(6) 2025, IT WAS OBSERVED THAT THE BLACK SHEATH COME OUT OF THE BIOPSY PORT ON THE SCOPE WHEN THEY WITHDREW THE FORCEPS BACK INTO THE ENDOSCOPE. IT WAS REPORTED THAT THE RX TUNNEL DID NOT DETACH INSIDE THE PATIENT. THEY HAVE TO TEST THE FIRST PATIENT (SOURCE) TO SEE IF THERE IS ANY FOR BLOOD-BORNE PATHOLOGY (BBP) WHICH COULD HAVE BEEN PASSED ON TO OTHER PATIENTS AT LATER PROCEDURES. THERE WERE NO PAT
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22311468 ↗MalfunctionJun 23, 2025Entrapment of Device; Problem with Sterilization; Entrapment of Device; Problem with Sterilization
NOTE: THIS REPORT PERTAINS TO ONE OF FOUR PROCEDURES INVOLVING ONE CRE RX BILIARY DILATATION BALLOON. IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CRE RX BILIARY DILATATION BALLOON WAS USED IN THE COMMON BILE DUCT DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE PERFORMED ON (B)(6) 2025. DURING THE PROCEDURE PERFORMED ON (B)(6) 2025, THE CRE RX TUNNEL (BLACK SHEATH) WAS DETACHED AND STUCK IN THE ENDOSCOPE. SCOPE WAS PUT THROUGH CLEANING PROCESS, AND INCLUDED MANUAL CLEAN, AND AUTO WASHING PROCEDURE. WITHOUT THE TEAM BEING AWARE, THE SCOPE WAS USED ON ANOTHER PROCEDURE ON (B)(6) 2025, STILL NO REALIZATION OF SHEATH INSIDE THE WORKING CHANNEL. THEN THE SCOPE WAS USED IN ANOTHER TWO SEPARATE PROCEDURES ON (B)(6) 2025, IN THE SECOND CASED PERFORMED ON (B)(6) 2025, IT WAS OBSERVED THAT THE BLACK SHEATH COME OUT OF THE BIOPSY PORT ON THE SCOPE WHEN THEY WITHDREW THE FORCEPS BACK INTO THE ENDOSCOPE. IT WAS REPORTED THAT THE RX TUNNEL DID NOT DETACH INSIDE THE PATIENT. THEY HAVE TO TEST THE FIRST PATIENT (SOURCE) TO SEE IF THERE IS ANY FOR BLOOD-BORNE PATHOLOGY (BBP) WHICH COULD HAVE BEEN PASSED ON TO OTHER PATIENTS AT LATER PROCEDURES. THERE WERE NO PAT
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22311317 ↗MalfunctionNov 12, 2024Burst Container or Vessel; Adverse Event Without Identified Device or Use Problem; Burst Container or Vessel; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CRE RX DILATATION BALLOON WAS USED IN THE DUODENAL PAPILLA DURING A PAPILLARY DILATION PROCEDURE PERFORMED ON (B)(6) 2024. DURING THE ONGOING USE OF THE DEVICE, THE BALLOON RUPTURED AT 3 ATM (10 MM). THE CUSTOMER REPORTED THAT NO PIECE OF THE BALLOON DETACHED INSIDE THE PATIENT. THE PROCEDURE WAS COMPLETED USING THE ORIGINAL DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20669026 ↗MalfunctionJun 8, 2022Burst Container or Vessel; Material Puncture/Hole; Burst Container or Vessel; Material Puncture/Hole
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CRE RX BILIARY DILATATION BALLOON WAS USED IN THE AMPULLA DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE ON (B)(6) 2022. DURING THE PROCEDURE, IT WAS NOTED THAT THE BALLOON DID NOT HOLD PRESSURE AND THE POPPED ON THE ELEVATOR. THE PROCEDURE WAS COMPLETED WITH ANOTHER CRE RX BILIARY DILATATION BALLOON. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14633955 ↗MalfunctionMar 9, 2022Burst Container or Vessel; Burst Container or Vessel
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CRE RX DILATATION BALLOON WAS USED DURING A PROCEDURE PERFORMED ON (B)(6) 2022. DURING THE PROCEDURE, IT WAS NOTED THAT THE BALLOON RUPTURED. THE PROCEDURE WAS COMPLETED WITH ANOTHER CRE RX DILATATION BALLOON. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13712142 ↗MalfunctionJan 7, 2022Material Integrity Problem; Material Integrity Problem
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CRE RX BILIARY DILATATION BALLOON WAS USED DURING A PROCEDURE PERFORMED ON (B)(6) 2021. DURING THE PROCEDURE, THE BALLOON WAS NOTED TO BE DAMAGED. THE PROCEDURE WAS COMPLETED WITH ANOTHER CRE RX BILIARY DILATION BALLOON. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. BOSTON SCIENTIFIC HAS BEEN UNABLE TO OBTAIN ADDITIONAL INFORMATION REGARDING THE EVENT TO DATE, DESPITE GOOD FAITH EFFORTS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13197486 ↗MalfunctionJan 5, 2022Burst Container or Vessel; Burst Container or Vessel
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CRE RX BILIARY DILATATION BALLOON WAS USED DURING A PROCEDURE PERFORMED ON AN UNKNOWN DATE. DURING THE PROCEDURE, THE BALLOON RUPTURED. THE PROCEDURE WAS COMPLETED WITH ANOTHER CRE RX BILIARY DILATATION BALLOON. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13168678 ↗MalfunctionMar 17, 2021Material Puncture/Hole; Use of Device Problem; Material Puncture/Hole; Use of Device Problem
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION, THAT A CRE RX BILIARY DILATATION BALLOON WAS USED, DURING A THERAPEUTIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE. PERFORMED ON (B)(6) 2021. IT WAS REPORTED, THAT DURING PREPARATION. THE BALLOON WAS TESTED, PRIOR TO USE IN A PROCEDURE. AND IT WAS NOTICED, THAT THE BALLOON WAS LEAKING, DUE TO A SMALL HOLE. THE PROCEDURE WAS COMPLETED WITH ANOTHER CRE RX BILIARY DILATATION BALLOON. NOTE: THE INSTRUCTIONS FOR USE (IFU), INDICATE THAT THE BALLOON SHOULD NOT BE PRE-INFLATED. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11509398 ↗MalfunctionApr 3, 2020Detachment of Device or Device Component; Detachment of Device or Device Component
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CRE RX BILIARY DILATATION BALLOON WAS USED IN THE PAPILLA OF VATER DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE PERFORMED ON AN UNKNOWN DATE. ACCORDING TO THE COMPLAINANT, WHEN THE DEVICE WAS REMOVED FROM THE PATIENT AFTER DILATION, IT WAS NOTED THAT THE BLACK RX TUNNEL CAME OFF FROM THE CATHETER INTO THE SCOPE. REPORTEDLY, THE SCOPE TOGETHER WITH THE DEVICE WAS REMOVED FROM THE PATIENT, AND THE PROCEDURE WAS COMPLETED AT THIS TIME. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. THE PATIENT'S CONDITION AT THE CONCLUSION OF THE PROCEDURE WAS REPORTED TO BE STABLE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9923176 ↗MalfunctionApr 3, 2020Detachment of Device or Device Component; Detachment of Device or Device Component
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CRE RX BILIARY DILATATION BALLOON WAS USED IN THE PAPILLA OF VATER DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE PERFORMED ON AN UNKNOWN DATE. ACCORDING TO THE COMPLAINANT, WHEN THE DEVICE WAS REMOVED FROM THE PATIENT AFTER DILATION, IT WAS NOTED THAT THE BLACK RX TUNNEL CAME OFF FROM THE CATHETER INTO THE SCOPE. REPORTEDLY, THE SCOPE TOGETHER WITH THE DEVICE WAS REMOVED FROM THE PATIENT, AND THE PROCEDURE WAS COMPLETED AT THIS TIME. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. THE PATIENT'S CONDITION AT THE CONCLUSION OF THE PROCEDURE WAS REPORTED TO BE STABLE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9923124 ↗MalfunctionJun 26, 2019Material Puncture/Hole; Material Puncture/Hole
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CRE RX BILIARY DILATATION BALLOON WAS USED IN THE PAPILLA DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE PERFORMED ON (B)(6) 2019. ACCORDING TO THE COMPLAINANT, DURING THE PROCEDURE, WHILE PHYSICIAN WAS PERFORMING SPHINCTEROPLASTY, A SMALL HOLE OPENED IN THE SIDE OF THE BALLOON AND WATER STARTED TO STREAM OUT CAUSING THE BALLOON TO DEFLATE. THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. THERE HAVE BEEN NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. THE PATIENT CONDITION AT THE CONCLUSION OF THE PROCEDURE WAS REPORTED TO BE STABLE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8737051 ↗
Other CATHETER, BILIARY, DIAGNOSTIC devices
- Hurricane™ RX M00545900Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls1 death705 reports
- MUSTANG™ H74939171060470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC384 reports
- CRE™ PRO M00558710Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC1 recall284 reports
- Hurricane™ RX M00545920Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls211 reports
- MUSTANG™ H74939171070470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC265 reports
- MUSTANG™ H74939171050470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC212 reports
- Hurricane™ RX M00545940Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls109 reports
- MUSTANG™ H74939171100470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC203 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page